Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 3/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 13/20 | 0.35 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.33 |
| ▸ | LIPE | Q05469 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5606762 | 1.00 | ROCK2 (0.37) | ROCK2SIGMAR1RORCHRH3LIPE | |
| SCHEMBL5605532 | 1.00 | ROCK2 (0.37) | ROCK2SIGMAR1RORCHRH3LIPE | |
| SCHEMBL1738865 | 1.00 | ROCK2 (0.37) | ROCK2SIGMAR1RORCHRH3LIPE | |
| SCHEMBL5610451 | 0.92 | ROCK2 (0.38) | ROCK2SIGMAR1LIPE | |
| SCHEMBL1738782 | 0.92 | ROCK2 (0.38) | ROCK2SIGMAR1LIPE | |
| SCHEMBL5606426 | 0.92 | ROCK2 (0.38) | ROCK2SIGMAR1LIPE | |
| SCHEMBL5606432 | 0.92 | ROCK2 (0.38) | ROCK2SIGMAR1LIPE | |
| SCHEMBL1738748 | 0.88 | SIGMAR1 (0.35) | ROCK2SIGMAR1LIPE | |
| SCHEMBL1740166 | 0.84 | FPR2 (0.36) | ROCK2SIGMAR1HRH3 | |
| SCHEMBL1738839 | 0.84 | FPR2 (0.36) | ROCK2SIGMAR1HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007026219-A2 | COMBINATIONS OF A 5-HT1B ANTAGONIST WITH A NORADRENALIN RE-UPTAKE INHIBITOR OR A SEROTONIN NORADRENALIN REUTAKE INHIBITOR FOR TREATING CNS CONDITIONS | PFIZER PRODUCTS INC. (US) | 2007-03-08 | — | — | WO | claimed |
| WO-2007026224-A2 | 5-HT1B ANTAGONIST COMPOSITION FOR DEPRESSION, ANXIETY AND COGNITION | PFIZER PRODUCTS INC. (US) | 2007-03-08 | — | — | WO | claimed |
| WO-2020183011-A1 | HTR1D INHIBITORS AND USES THEREOF IN THE TREATMENT OF CANCER | INSTITUT CURIE (FR) | 2020-09-17 | — | — | WO | disclosed |
| WO-2007026219-A2 | COMBINATIONS OF A 5-HT1B ANTAGONIST WITH A NORADRENALIN RE-UPTAKE INHIBITOR OR A SEROTONIN NORADRENALIN REUTAKE INHIBITOR FOR TREATING CNS CONDITIONS | PFIZER PRODUCTS INC. (US) | 2007-03-08 | — | — | WO | disclosed |
| WO-2007026224-A2 | 5-HT1B ANTAGONIST COMPOSITION FOR DEPRESSION, ANXIETY AND COGNITION | PFIZER PRODUCTS INC. (US) | 2007-03-08 | — | — | WO | disclosed |